Clinical Study of Modified Tiaopi Huxin Formula for Treating Hypertension with Deficiency of Heart and Spleen
Objective:To observe the clinical efficacy of Modified Tiaopi Huxin formula for treating hypertension with deficiency of the heart and spleen.Methods:Sixty patients were divided into treatment group and control group by random number table method,with 30 cases in each group.the patients of control group were treated with conventional western medicine,and the patients of treatment group were treated with Modified Tiaopi Huxin formula on the basis of control group.Traditional Chinese medicine syndrome score,traditional Chinese medicine syndrome effect,Pittsburgh Sleep Quality Index(PSQI)score,Quality of Life Evaluation Scale(SF-36)score and other indexes were compared before and after treatment in the two groups.Results:After 4 weeks of treatment,the traditional Chinese medicine syndrome scores of the two groups were less than that before treatment(P＜0.05),and those in the treatment group were less than those in the control group(P＜0.05).The total clinical efficacy of traditional Chinese medicine syndromes in the treatment group was higher than that in the control group,the difference was statistically significant(P＜0.05).After treatment,PSQI score and SF-36 score of both groups were improved compared with those before treatment(P＜0.05),and the improvement degree of the treatment group was better than that of the control group(P＜0.05).Conclusion:Modified Tiaopi Huxin formula for treating hypertension could alleviate patients'clinical symptoms,enhance sleep quality and improve the quality of life.
hypertensiondeficiency of heart and spleenModified Tiaopi Huxin formulasleep qualityquality of life
万方数据
维普
